We are following the latest developments with COVID-19 and the recommendations by the Centers for Disease Control and Prevention. 

Angela Smith, MD, MS, FACS, is one of four recipients of the prize, which is awarded to faculty members who exemplify groundbreaking and innovative research.

Thomas Alexander, MD, MPH, and colleagues report on their work to help establish a pediatric hematology-oncology training curriculum in Ethiopia.

Lisa A. Carey, MD, FASCO, is the only breast cancer expert in N.C. and the Southeastern U.S. to earn the honor from Expertscape.

Adam Goldstein, MD, MPH, Trevor Jolly, MBBS, and Kimberly Shoenbill, MD, PhD, published an editorial in JAMA that states the case for more intensive smoking cessation programs for cancer patients.

Zongchao Han, MD, PhD, Barbara Savoldo, MD, PhD, and colleagues report in Nature Cancer they used a combination of CAR-Ts and interleukin (IL)-15 to treat retinoblastoma in a mouse model.

Yemi Ogunleye, MD, SM, and colleagues from UNC published findings from a study that analyzed hospitalizations due to lymphedema with the goal to identify factors associated with poor outcomes.

UNC Lineberger, Yale Cancer Center and Fox Chase Comprehensive Cancer Center will use the grant to develop better treatments for head and neck squamous cell carcinoma.

New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.

One in seven black women with breast cancer had delays in starting treatment according to a study led by UNC Lineberger researchers Melissa Troester, PhD, and Marc Emerson, PhD.